Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
FAMPYRA Ret Tabl 10 mg 56 Stk
Drug
Fampyra, Retardtabletten
Multiple Sklerose
01.99.0. – various
HAM – Human medicine
RETT – Prolonged-release tablet
S – synthetic products for human use
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
8/22/2019
12/31/9999
Dosage strength
Fampyra 10 mg, Retardtabletten
Multiple Sklerose
01
Z – approved
Package
7680671390025
No information made available
A/R – Authorised / referenced
56 tablet(s)
002
Z – approved
Declaration
Component
10 mg fampridinum
cellulosum microcristallinum
hypromellosum
silica colloidalis anhydrica
magnesii stearas
hypromellosum
macrogolum 400
titanii dioxidum
hypromellosum
silica colloidalis anhydrica
magnesii stearas
hypromellosum
macrogolum 400
titanii dioxidum
Spezialitätenliste***
SL
-
-
260.15
None
Yes
10%
No
Authorisation holder
7601001002029
Merz Pharma (Schweiz) AG
Hegenheimermattweg 57
4123 Allschwil (BL)
Hegenheimermattweg 57
4123 Allschwil (BL)
Date of revision of the text
1/1/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.